Making Breast Tumors Tamoxifen-Sensitive.
A new study offers a potential treatment strategy for basal-like breast tumors. Researchers found that disrupting platelet-derived growth factor signaling-either genetically or with an antibody that blocks one form of the growth factor-can cause tumors to change to the luminal subtype, which is susceptible to antiestrogen therapies.